Vestal Point Capital, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.32 Trillion distributed in 69 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Insmed Inc with a value of $117B, Jazz Pharmaceuticals PLC with a value of $100B, Cytokinetics Inc with a value of $79.2B, Inari Medical, Inc. with a value of $63.9B, and Arcellx, Inc. with a value of $56.4B.

Examining the 13F form we can see an decrease of $22.5B in the current position value, from $1.34T to 1.32T.

Vestal Point Capital, LP is based out at New York, NY

Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.32 Trillion
Healthcare: $1.09 Trillion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 69
  • Current Value $1.32 Trillion
  • Prior Value $1.34 Trillion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 23 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.